NewsRx

Search our medical news database

Harborview Medical Center

AMG531 strongly stimulates megakarypoiesis in vitro

Published in Physician Business Week, March 16th, 2004

AMG531 strongly stimulates megakarypoiesis in cultured cells.

TPO "plays a pivotal role in megakaryopoiesis," and "initiates its biological effects by binding to its receptor Mp1," scientists in Seattle explained.

In a study conducted by V.C. Broudy and coauthors at Harborview Medical Center, a "recombinant protein consisting of a carrier Fc domain linked to multiple Mpl-binding domains was constructed" and named AMG531.

"To define the biological activity of AMG531," the collaborators "examined the ability of AMG531 to support CFU-Meg growth and to promote megakaryocyte maturation in vitro."

"AMG531 stimulates...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook